“Pathogens such as C. difficile are common in hospitals and long-term care facilities, posing a major health threat,” George Weinstock, PhD, a professor with The Jackson Laboratory, said in a statement. “[W]e are developing new techniques to identify these pathogens, as well as to study the wide-ranging health effects of the multitudes of microorganisms that inhabit each of us.”
The project will use next-generation DNA sequencing to get a fuller picture of the microbiome and ultimately develop techniques for diagnosing and treating infectious disease, according to the researchers.
More articles on infection control:
Brazil reports first case of superbug resistant to last resort antibiotics
UT researchers investigate ways to prevent large-scale bacterial outbreaks
Genome researchers dive deep to differentiate dangerous Staph
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
